The company has received final approval from the USFDA to market its product which is a generic version of Bayer HealthCare Pharmaceutical ...

Drug major Lupin has launched its Tri-Lo-Marzia tablets, an oral contraceptive drug, in the US market after getting approval from the Ameri...

Drugs Technical Advisory Board's recommendations are based on studies conducted by the ICMR in India for injectable contraceptives.

The approval marks the company's 12th oral contraceptive and 2nd extended-cycle oral contraceptive authorised for distribution by the USFDA.

The shareholders’ agreement between AIF Capital and the promoters gives a drag-along right to the fund in case of an exit.

“TA Associates is in talks with the investors and Taparias, the promoters. The deal is expected to be signed post Diwali,” one of the perso...

Lupin said it has received US health regulator's approval to market generic version of Ortho-Novum tablets in the American market.

As per the IMS data, the total sales for branded and generic sales for the product stood at $ 361 million for the year ended December 2012.

Lupin said that it has received final approval from the US health regulator to sell its generic oral contraceptive Levonorgestrel and Ethin...

Lupin today said it has received US health regulator's approval to market Drospirenone and Ethinyl Estradiol Tablets, an oral contraceptive...

Drug firm Lupin today said its subsidiary has received American health regulator's approval to market its generic oral contraceptive tablet...

The country's second-largest pharmaceuticals company, Cipla, is in talks with an international health group to expand its contraceptive pil...

“This product is being recalled due to an out of specification test result for an individual unspecified impurity, identified as Bisphenol-...

Lupin has received approval from USFDA to sell 'LoSeasonique' tablets, an oral contraceptive drug, in the American mkt.

Baring Private Equity Partners (India) is the front-runner to buy about 15% stake in Mumbai-based drugmaker Famy Care for around $40 millio...

Mylan, the third-largest generic drug maker globally, is in advanced stages of talks to pick up around 15 per cent stake in Famy Care, Indi...

Pharma major Cipla's toll-free helpline number on emergency contraceptives receives 300 calls per day, a good 40% of them from men. Investo...